Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stroke prevention in atrial fibrillation--things can only get better.

× No keyword cloud information.

16 in total

1. Stroke prevention in atrial fibrillation: antiplatelet therapy revisited.

Authors: Gregory Y H Lip; Timothy Watson
Journal: Eur Heart J Date: 2007-04-12 Impact factor: 29.983

2. Identification of patients with atrial fibrillation in general practice: a study of screening methods.

Authors: M Sudlow; H Rodgers; R A Kenny; R Thomson
Journal: BMJ Date: 1998-08-01

3. Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.

Authors: Gregory Y H Lip; Deirdre Lane; Carl Van Walraven; Robert G Hart
Journal: Stroke Date: 2006-08-03 Impact factor: 7.914

4. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors:
Journal: BMJ Date: 2002-01-12

5. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors: E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal: Circulation Date: 1998-09-08 Impact factor: 29.690

Review 6. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.

Authors: Gregory Y H Lip; Steven J Edwards
Journal: Thromb Res Date: 2005-09-29 Impact factor: 3.944

7. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.

Authors: Niteesh K Choudhry; Geoffrey M Anderson; Andreas Laupacis; Dennis Ross-Degnan; Sharon-Lise T Normand; Stephen B Soumerai
Journal: BMJ Date: 2006-01-10

8. Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi.

Authors: W E Wysokinski; W G Owen; D N Fass; D D Patrzalek; L Murphy; R D McBane
Journal: J Thromb Haemost Date: 2004-09 Impact factor: 5.824

Review 9. Aspirin dose for the prevention of cardiovascular disease: a systematic review.

Authors: Charles L Campbell; Susan Smyth; Gilles Montalescot; Steven R Steinhubl
Journal: JAMA Date: 2007-05-09 Impact factor: 56.272

10. National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing.

Authors: Azra Mahmud; Kathleen Bennett; Ifeanyi Okechukwu; John Feely
Journal: Br J Clin Pharmacol Date: 2007-06-06 Impact factor: 4.335